$1.19
4.03% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US4277461020
Symbol
HRTX
Sector
Industry

Heron Therapeutics Inc Target price 2024 - Analyst rating & recommendation

Heron Therapeutics Inc Classifications & Recommendation:

Buy
100%

Heron Therapeutics Inc Price Target

Target Price $6.25
Price $1.19
Potential
Number of Estimates 4
4 Analysts have issued a price target Heron Therapeutics Inc 2025 . The average Heron Therapeutics Inc target price is $6.25. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 4 analysts: 4 Analysts recommend Heron Therapeutics Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Heron Therapeutics Inc stock has an average upside potential 2025 of . Most analysts recommend the Heron Therapeutics Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 127.04 140.90
17.99% 10.91%
Net Margin -95.53% -14.00%
59.40% 85.34%

4 Analysts have issued a sales forecast Heron Therapeutics Inc 2024 . The average Heron Therapeutics Inc sales estimate is

$141m
Unlock
. This is
2.29% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$142m 2.87%
Unlock
, the lowest is
$140m 1.64%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $127m 17.99%
2024
$141m 10.91%
Unlock
2025
$163m 15.67%
Unlock
2026
$180m 10.67%
Unlock
2027
$213m 17.90%
Unlock
2028
$255m 19.87%
Unlock

4 Heron Therapeutics Inc Analysts have issued a net profit forecast 2024. The average Heron Therapeutics Inc net profit estimate is

$-19.7m
Unlock
. This is
27.78% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-15.2m 44.44%
Unlock
, the lowest is
$-22.8m 16.65%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-121m 52.10%
2024
$-19.7m 83.75%
Unlock
2025
$-8.3m 57.71%
Unlock
2026
$8.1m 197.00%
Unlock
2027
$31.9m 293.82%
Unlock
2028
$54.6m 71.41%
Unlock

Net Margin

2023 -95.53% 59.40%
2024
-14.00% 85.34%
Unlock
2025
-5.12% 63.43%
Unlock
2026
4.49% 187.70%
Unlock
2027
14.98% 233.63%
Unlock
2028
21.42% 42.99%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.80 -0.13
52.10% 83.75%
P/E negative
EV/Sales 2.04

4 Analysts have issued a Heron Therapeutics Inc forecast for earnings per share. The average Heron Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.13
Unlock
. This is
27.78% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.10 44.44%
Unlock
, the lowest is
$-0.15 16.67%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.80 52.10%
2024
$-0.13 83.75%
Unlock
2025
$-0.06 53.85%
Unlock
2026
$0.05 183.33%
Unlock
2027
$0.21 320.00%
Unlock
2028
$0.36 71.43%
Unlock

P/E ratio

Current -6.45 1,190.00%
2024
-9.15 41.86%
Unlock
2025
-21.64 136.50%
Unlock
2026
22.31 203.10%
Unlock
2027
5.67 74.59%
Unlock
2028
3.31 41.62%
Unlock

Based on analysts' sales estimates for 2024, the Heron Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.09 20.11%
2024
2.04 2.25%
Unlock
2025
1.77 13.54%
Unlock
2026
1.60 9.64%
Unlock
2027
1.35 15.18%
Unlock
2028
1.13 16.58%
Unlock

P/S ratio

Current 1.31 87.59%
2024
1.28 2.24%
Unlock
2025
1.11 13.55%
Unlock
2026
1.00 9.64%
Unlock
2027
0.85 15.18%
Unlock
2028
0.71 16.58%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today